Dr. Pepper ( DPS) added to Conviction Buy list at Goldman Sachs. Stock has rallied over the past month, buy US soda volumes are moving higher and industry pricing has firmed. New $23 price target. Goldman ( GS) estimates, target raised at Barclays Capital. Target now $105 a share. Estimates also boosted, given the company's recent earnings upside. Equal-weight rating. Intel ( INTC) estimates, target raised at Goldman. Shares now seen reaching $13. Estimates also increased, to reflect better sales and margins. That said, maintaining Neutral rating, based on valuation. Raymond James ( RJF) numbers cut at Goldman through 2011. Company warned of higher bank losses, which will cut into book value. Neutral rating and new $18 price target.